Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer NCT01266642 Ductal Breast C...
Invasive Breast...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
External Beam R...
External Beam R...
Hypofractionate...
Laboratory Biom...
Quality-of-Life...
Questionnaire A...
Whole Breast Ir...
Whole Breast Ir...
40 Years - M.D. Anderson Cancer Center View Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC NCT02593175 Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage III Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Triple-Negative...
Carboplatin
Paclitaxel
Panitumumab
18 Years - M.D. Anderson Cancer Center View Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC NCT02593175 Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage III Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Triple-Negative...
Carboplatin
Paclitaxel
Panitumumab
18 Years - M.D. Anderson Cancer Center View The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer NCT03454529 Invasive Breast...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Laboratory Biom...
Simvastatin
19 Years - Barbara Ann Karmanos Cancer Institute View The Role of Lifestyle Factors in Breast Cancer-Related Outcomes NCT02079662 Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage III Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Behavioral, Psy...
Best Practice
Cognitive Inter...
Computer-Assist...
Counseling
Exercise Interv...
Laboratory Biom...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center View Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence NCT04054557 Stage 0 Breast ...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Stage III Breas...
Telemedicine
Best Practice
Questionnaire A...
Quality-of-Life...
Survey Administ...
Behavioral Inte...
Educational Int...
18 Years - Thomas Jefferson University View Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery NCT00861705 Male Breast Car...
Stage IIA Breas...
Stage IIB Breas...
Stage IIIA Brea...
Triple-Negative...
Bevacizumab
Carboplatin
Cyclophosphamid...
Doxorubicin Hyd...
Laboratory Biom...
Paclitaxel
18 Years - National Cancer Institute (NCI) View SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer NCT03411070 Positive Axilla...
Stage 0 Breast ...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage III Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Implanted Medic...
Therapeutic Con...
18 Years - Jonsson Comprehensive Cancer Center View Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative NCT02276443 Invasive Breast...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage III Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Triple-Negative...
Chemotherapy
Immunotherapy
Laboratory Biom...
Lymph Node Biop...
Ultrasonography
18 Years - M.D. Anderson Cancer Center View Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer NCT02598557 Stage 0 Breast ...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Exemestane
Laboratory Biom...
Pharmacological...
Placebo Adminis...
Quality-of-Life...
Questionnaire A...
Therapeutic Con...
- 75 Years National Cancer Institute (NCI) View Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery NCT03317405 Breast Ductal C...
Breast Lobular ...
Stage 0 Breast ...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage III Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Endoxifen Hydro...
Placebo Adminis...
Questionnaire A...
18 Years - National Cancer Institute (NCI) View Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Surgery NCT02654119 HER2 Positive B...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Cyclophosphamid...
Laboratory Biom...
Paclitaxel
Trastuzumab
20 Years - University of Nebraska View Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer NCT02689427 Invasive Breast...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage III Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Triple-Negative...
Axillary Lymph ...
Enzalutamide
Laboratory Biom...
Lymph Node Biop...
Paclitaxel
Therapeutic Con...
18 Years - M.D. Anderson Cancer Center View Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC NCT02593175 Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage III Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Triple-Negative...
Carboplatin
Paclitaxel
Panitumumab
18 Years - M.D. Anderson Cancer Center View Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer NCT00005970 Breast Adenocar...
HER2 Positive B...
Stage IA Breast...
Stage IB Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage IIIA Brea...
Aromatase Inhib...
Cyclophosphamid...
Doxorubicin Hyd...
Laboratory Biom...
Paclitaxel
Tamoxifen Citra...
Trastuzumab
18 Years - National Cancer Institute (NCI) View Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors NCT03319342 Cancer Survivor
Stage 0 Breast ...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage IIIA Brea...
Behavioral Inte...
Behavioral Inte...
Behavioral Inte...
Behavioral Inte...
Questionnaire A...
19 Years - Jonsson Comprehensive Cancer Center View Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer NCT03012100 Bilateral Breas...
Breast Inflamma...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage III Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Triple-Negative...
Unilateral Brea...
Cyclophosphamid...
Laboratory Biom...
Multi-epitope F...
Placebo Adminis...
Sargramostim
18 Years - Academic and Community Cancer Research United View Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) NCT00310180 Breast Adenocar...
Hormone Recepto...
Stage IA Breast...
Stage IB Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage IIIB Brea...
Anastrozole
Exemestane
Laboratory Biom...
Letrozole
Quality-of-Life...
Radiation Thera...
Tamoxifen Citra...
18 Years - 75 Years National Cancer Institute (NCI) View The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer NCT03454529 Invasive Breast...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Laboratory Biom...
Simvastatin
19 Years - Barbara Ann Karmanos Cancer Institute View The Role of Lifestyle Factors in Breast Cancer-Related Outcomes NCT02079662 Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage III Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Behavioral, Psy...
Best Practice
Cognitive Inter...
Computer-Assist...
Counseling
Exercise Interv...
Laboratory Biom...
Quality-of-Life...
Questionnaire A...
18 Years - M.D. Anderson Cancer Center View Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors NCT03319342 Cancer Survivor
Stage 0 Breast ...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage IIIA Brea...
Behavioral Inte...
Behavioral Inte...
Behavioral Inte...
Behavioral Inte...
Questionnaire A...
19 Years - Jonsson Comprehensive Cancer Center View Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) NCT00310180 Breast Adenocar...
Hormone Recepto...
Stage IA Breast...
Stage IB Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage IIIB Brea...
Anastrozole
Exemestane
Laboratory Biom...
Letrozole
Quality-of-Life...
Radiation Thera...
Tamoxifen Citra...
18 Years - 75 Years National Cancer Institute (NCI) View Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer NCT03077841 Ductal Breast C...
Early-Stage Bre...
Invasive Breast...
Stage 0 Breast ...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Laboratory Biom...
Partial Breast ...
Questionnaire A...
50 Years - M.D. Anderson Cancer Center View Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative NCT02276443 Invasive Breast...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage III Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Triple-Negative...
Chemotherapy
Immunotherapy
Laboratory Biom...
Lymph Node Biop...
Ultrasonography
18 Years - M.D. Anderson Cancer Center View Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer NCT02598557 Stage 0 Breast ...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Exemestane
Laboratory Biom...
Pharmacological...
Placebo Adminis...
Quality-of-Life...
Questionnaire A...
Therapeutic Con...
- 75 Years National Cancer Institute (NCI) View Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer NCT03077841 Ductal Breast C...
Early-Stage Bre...
Invasive Breast...
Stage 0 Breast ...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Laboratory Biom...
Partial Breast ...
Questionnaire A...
50 Years - M.D. Anderson Cancer Center View Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer NCT03568526 Peripheral Neur...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Educational Int...
Exercise Interv...
Quality-of-Life...
Questionnaire A...
Survey Administ...
- Ohio State University Comprehensive Cancer Center View Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery NCT00770809 Male Breast Car...
Stage IIA Breas...
Stage IIB Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Laboratory Biom...
Lapatinib Ditos...
Paclitaxel
Trastuzumab
18 Years - National Cancer Institute (NCI) View Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer NCT02003209 HER2-Positive B...
Hormone Recepto...
Stage IB Breast...
Stage IIA Breas...
Stage IIB Breas...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Aromatase Inhib...
Carboplatin
Cytology Specim...
Docetaxel
Goserelin Aceta...
Laboratory Biom...
Pertuzumab
Quality-of-Life...
Therapeutic Con...
Trastuzumab
Whole Breast Ir...
18 Years - National Cancer Institute (NCI) View Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer NCT01245712 Breast Adenocar...
Ductal Breast C...
Invasive Breast...
Stage 0 Breast ...
Stage I Breast ...
Stage IA Breast...
Stage IB Breast...
Stage II Breast...
Stage IIA Breas...
Stage IIB Breas...
Accelerated Par...
Proton Beam Rad...
Quality-of-Life...
18 Years - M.D. Anderson Cancer Center View